Literature DB >> 11456372

Physiopathological basis of bone turnover.

L Masi1, M L Brandi.   

Abstract

Bone remodeling involves the continuous removal of bone (bone resorption) followed by synthesis of new bone matrix and subsequent mineralization (bone formation). The principal cells that mediate the boneforming processes of the skeleton are osteoblast cells. They are responsible for the production of the matrix constituents and the differentiation of osteoblasts from stromal cell precursors is stimulated by several hormonal and non-hormonal molecules. On the other hand, the osteoclasts are giant multinucleated cells responsible of bone resorption. They are formed in the bone marrow and mature cells are stimulated by PTH and locally acting agents such as transforming growth factor alpha (TGFalpha), tumor necrosis factor (TNF) interleukin 1 (IL-1) and interleukin 6 (IL-6). The first events during bone remodeling is osteoclast activation, followed by osteoclast formation, polarization constitution of the ruffled border, resorption and ultimately apoptosis. Osteoclast apoptosis is followed by a series of sequential changes in cells in the osteoblast lineage, including osteoblast chemotaxis, proliferation and differentiation, which in turn is followed by formation of mineralized bone and cessation of osteoblast activity. The final phase of the formation process is cessation of osteoblast activity. The resorption lacunae are usually repaired either completely or almost completely. Understanding the sequence of cellular events may be important to better know the mechanisms responsible for bone loss that occurs in age and in several pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456372

Source DB:  PubMed          Journal:  Q J Nucl Med        ISSN: 1125-0135


  6 in total

1.  Correlation between bone mineral density and oxidative stress in postmenopausal women.

Authors:  Tripti Sharma; Najmul Islam; Jamal Ahmad; Nishat Akhtar; Mujahid Beg
Journal:  Indian J Endocrinol Metab       Date:  2015 Jul-Aug

2.  Protective effects of remifentanil against H2O2-induced oxidative stress in human osteoblasts.

Authors:  Ji-Young Yoon; Do-Wan Kim; Eun-Jung Kim; Bong-Soo Park; Ji-Uk Yoon; Hyung-Joon Kim; Jeong-Hoon Park
Journal:  J Dent Anesth Pain Med       Date:  2016-12-31

3.  Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats.

Authors:  Carina Cardemil; Ibrahim Elgali; Wei Xia; Lena Emanuelsson; Birgitta Norlindh; Omar Omar; Peter Thomsen
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

4.  Oxidative stress and bone resorption interplay as a possible trigger for postmenopausal osteoporosis.

Authors:  Carlo Cervellati; Gloria Bonaccorsi; Eleonora Cremonini; Arianna Romani; Enrica Fila; Maria Cristina Castaldini; Stefania Ferrazzini; Melchiorre Giganti; Leo Massari
Journal:  Biomed Res Int       Date:  2014-01-12       Impact factor: 3.411

5.  Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia.

Authors:  Carlo Cervellati; Arianna Romani; Eleonora Cremonini; Carlo M Bergamini; Enrica Fila; Monica Squerzanti; Pantaleo Greco; Leo Massari; Gloria Bonaccorsi
Journal:  Oxid Med Cell Longev       Date:  2015-11-09       Impact factor: 6.543

6.  Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone.

Authors:  Ye Li; Ligang Jie; Austin Y Tian; Shenrong Zhong; Mason Y Tian; Yixiu Zhong; Yining Wang; Hongwei Li; Jinlong Li; Xiaoyan Sun; Hongyan Du
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.